je.st
news
Vertex Pharmaceuticals Incorporated (VRTX) Earns Outperform Rating from Leerink Swann
2016-04-10 19:10:39| Biotech - Topix.net
A number of other research firms also recently weighed in on VRTX. Piper Jaffray reaffirmed an overweight rating and set a $180.00 price target on shares of Vertex Pharmaceuticals in a research note on Tuesday, January 5th.
Tags: rating
incorporated
pharmaceuticals
earns
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||